2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $23B | $34B | $34B | $36B | $38B |
Cost of Revenue | $19B | $29B | $29B | $29B | $31B |
Gross Profit | $3.7B | $5.5B | $5.5B | $6.1B | $6.5B |
Gross Profit % | 16% | 16% | 16% | 17% | 17% |
R&D Expenses | $0 | $0 | $0 | $0 | $0 |
2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$226M | $265M | $265M | $506M | $494M |
Dep. & Amort. | $422M | $372M | $372M | $395M | $438M |
Def. Tax | -$51M | $17M | $17M | $9M | -$10M |
Stock Comp. | $40M | $45M | $45M | $56M | $63M |
Chg. in WC | $154M | $43M | $43M | $117M | $18M |
2021 | 2022 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $828M | $211M | $211M | $269M | $59M |
ST Investments | $0 | $0 | $0 | $1M | $0 |
Cash & ST Inv. | $828M | $211M | $211M | $269M | $59M |
Receivables | $1.1B | $1.8B | $1.8B | $2B | $2.1B |
Inventory | $1.3B | $1.6B | $1.6B | $1.6B | $1.6B |
U.S. Foods achieved record 2024 full-year earnings of $1.74 billion, with adjusted EBITDA margin expanding by 22 basis points to 4.6% and adjusted EPS growing 20% to $3.15.
The company provided fiscal 2025 guidance, expecting 4%-6% net sales growth, 2%-4% total case growth, 8%-12% adjusted EBITDA growth, and 17%-23% adjusted diluted EPS growth.
Key initiatives included $230 million in cost savings, a 3%-5% annual productivity improvement target, and a focus on private label brand penetration, which reached nearly 53% by the end of 2024.
U.S. Foods continued to gain market share in independent restaurants, healthcare, and hospitality, with independent case volume growing 3.2% in Q4 despite macro challenges.
The company plans to deploy over $4 billion in cash flow from 2025-2027, with approximately $2 billion allocated for share repurchases and continued investments in growth and M&A opportunities.